Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients

Keith K. Lau, Gerre M. Berg, Yolanda G. Schjoneman, Richard V Perez, Lavjay Butani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To determine the safety and efficacy of a novel steroid minimization protocol after renal transplantation at a single Northern California center. Introduction: We have previously reported our experience on the short-term outcomes in eight children using our steroid minimization protocol. Herein, we present our ongoing experience in using this regimen in 20 children. Methods: Children receiving immunosuppression with a steroid minimization protocol at our center from 1/04 - 12/08 (Group 2) were retrospectively compared with 20 controls (Group 1). Results: At one-month follow-up, Group 2 was observed to have lower eGFR, hemoglobin, white cell count, and cholesterol. The incidence of adverse events during the first yr was comparable. Three patients in Group 1 displayed histological evidence of acute rejection, one patient in Group 2 developed humoral rejection; another patient in Group 2 had sub-clinical rejection. Surgical complications were observed in 20% of patients in both groups. While 10% of patients in Group 1 developed diabetes mellitus, none was observed in Group 2. Thirty and 40% of patients in Groups 1 and 2, respectively, suffered from infectious complications during the first yr. Conclusions: Our novel steroid minimization immunosuppression is safe in children and associated with no increased risk of rejection and infection.

Original languageEnglish (US)
Pages (from-to)488-495
Number of pages8
JournalPediatric Transplantation
Volume14
Issue number4
DOIs
StatePublished - Jun 2010

Fingerprint

Immunosuppression
Steroids
Pediatrics
Kidney
Kidney Transplantation
Transplant Recipients
Diabetes Mellitus
Hemoglobins
Cell Count
Cholesterol
Safety
Control Groups
Incidence
Infection

Keywords

  • Pediatrics
  • Renal transplantation
  • Steroid discontinuation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients. / Lau, Keith K.; Berg, Gerre M.; Schjoneman, Yolanda G.; Perez, Richard V; Butani, Lavjay.

In: Pediatric Transplantation, Vol. 14, No. 4, 06.2010, p. 488-495.

Research output: Contribution to journalArticle

@article{10692014b99e4225a97a4d7a1ebe01cd,
title = "Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients",
abstract = "Purpose: To determine the safety and efficacy of a novel steroid minimization protocol after renal transplantation at a single Northern California center. Introduction: We have previously reported our experience on the short-term outcomes in eight children using our steroid minimization protocol. Herein, we present our ongoing experience in using this regimen in 20 children. Methods: Children receiving immunosuppression with a steroid minimization protocol at our center from 1/04 - 12/08 (Group 2) were retrospectively compared with 20 controls (Group 1). Results: At one-month follow-up, Group 2 was observed to have lower eGFR, hemoglobin, white cell count, and cholesterol. The incidence of adverse events during the first yr was comparable. Three patients in Group 1 displayed histological evidence of acute rejection, one patient in Group 2 developed humoral rejection; another patient in Group 2 had sub-clinical rejection. Surgical complications were observed in 20{\%} of patients in both groups. While 10{\%} of patients in Group 1 developed diabetes mellitus, none was observed in Group 2. Thirty and 40{\%} of patients in Groups 1 and 2, respectively, suffered from infectious complications during the first yr. Conclusions: Our novel steroid minimization immunosuppression is safe in children and associated with no increased risk of rejection and infection.",
keywords = "Pediatrics, Renal transplantation, Steroid discontinuation",
author = "Lau, {Keith K.} and Berg, {Gerre M.} and Schjoneman, {Yolanda G.} and Perez, {Richard V} and Lavjay Butani",
year = "2010",
month = "6",
doi = "10.1111/j.1399-3046.2009.01254.x",
language = "English (US)",
volume = "14",
pages = "488--495",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients

AU - Lau, Keith K.

AU - Berg, Gerre M.

AU - Schjoneman, Yolanda G.

AU - Perez, Richard V

AU - Butani, Lavjay

PY - 2010/6

Y1 - 2010/6

N2 - Purpose: To determine the safety and efficacy of a novel steroid minimization protocol after renal transplantation at a single Northern California center. Introduction: We have previously reported our experience on the short-term outcomes in eight children using our steroid minimization protocol. Herein, we present our ongoing experience in using this regimen in 20 children. Methods: Children receiving immunosuppression with a steroid minimization protocol at our center from 1/04 - 12/08 (Group 2) were retrospectively compared with 20 controls (Group 1). Results: At one-month follow-up, Group 2 was observed to have lower eGFR, hemoglobin, white cell count, and cholesterol. The incidence of adverse events during the first yr was comparable. Three patients in Group 1 displayed histological evidence of acute rejection, one patient in Group 2 developed humoral rejection; another patient in Group 2 had sub-clinical rejection. Surgical complications were observed in 20% of patients in both groups. While 10% of patients in Group 1 developed diabetes mellitus, none was observed in Group 2. Thirty and 40% of patients in Groups 1 and 2, respectively, suffered from infectious complications during the first yr. Conclusions: Our novel steroid minimization immunosuppression is safe in children and associated with no increased risk of rejection and infection.

AB - Purpose: To determine the safety and efficacy of a novel steroid minimization protocol after renal transplantation at a single Northern California center. Introduction: We have previously reported our experience on the short-term outcomes in eight children using our steroid minimization protocol. Herein, we present our ongoing experience in using this regimen in 20 children. Methods: Children receiving immunosuppression with a steroid minimization protocol at our center from 1/04 - 12/08 (Group 2) were retrospectively compared with 20 controls (Group 1). Results: At one-month follow-up, Group 2 was observed to have lower eGFR, hemoglobin, white cell count, and cholesterol. The incidence of adverse events during the first yr was comparable. Three patients in Group 1 displayed histological evidence of acute rejection, one patient in Group 2 developed humoral rejection; another patient in Group 2 had sub-clinical rejection. Surgical complications were observed in 20% of patients in both groups. While 10% of patients in Group 1 developed diabetes mellitus, none was observed in Group 2. Thirty and 40% of patients in Groups 1 and 2, respectively, suffered from infectious complications during the first yr. Conclusions: Our novel steroid minimization immunosuppression is safe in children and associated with no increased risk of rejection and infection.

KW - Pediatrics

KW - Renal transplantation

KW - Steroid discontinuation

UR - http://www.scopus.com/inward/record.url?scp=77952281082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952281082&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2009.01254.x

DO - 10.1111/j.1399-3046.2009.01254.x

M3 - Article

C2 - 19849807

AN - SCOPUS:77952281082

VL - 14

SP - 488

EP - 495

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

ER -